{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:05:29Z","timestamp":1780985129420,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,17]]},"DOI":"10.7759\/cureus.28101","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T14:25:52Z","timestamp":1660746352000},"source":"Crossref","is-referenced-by-count":2,"title":["The Prevalence and Level of Awareness of Medication Overuse Headache in Qassim Province, Saudi Arabia: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Samer A","family":"Almuqairsha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad I","family":"Aldekhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah I","family":"Aldekhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed H","family":"Alresaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulaiman S","family":"Almarshoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman A","family":"Alashqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Algosair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitham H","family":"Alresaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202","article-title":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition","volume":"38","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018, 38.1-211. 10.1177\/0333102417738202","journal-title":"Cephalalgia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.59.7.1011","article-title":"Features of medication overuse headache following overuse of different acute headache drugs","volume":"59","author":"Limmroth V","year":"2002","unstructured":"Limmroth V, Katsarava Z, Fritsche G, et al.. Features of medication overuse headache following overuse of different acute headache drugs. Neurology. 2002, 59:1011-4. 10.1212\/wnl.59.7.1011","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/2042098616653390","article-title":"Medication-overuse headache: a perspective review","volume":"7","author":"Westergaard ML","year":"2016","unstructured":"Westergaard ML, Munksgaard SB, Bendtsen L, et al.. Medication-overuse headache: a perspective review. Ther Adv Drug Saf. 2016, 7:147-58. 10.1177\/2042098616653390","journal-title":"Ther Adv Drug Saf"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/2042098614522683","article-title":"Medication-overuse headache: epidemiology, diagnosis and treatment","volume":"5","author":"Kristoffersen ES","year":"2014","unstructured":"Kristoffersen ES, Lundqvist C. Medication-overuse headache: epidemiology, diagnosis and treatment. Ther Adv Drug Saf. 2014, 5:87-99. 10.1177\/2042098614522683","journal-title":"Ther Adv Drug Saf"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","year":"2015","unstructured":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013. a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015, 386:743-800. 10.1016\/S0140-6736(15)60692-4","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/0333102413512033","article-title":"Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review","volume":"34","author":"Westergaard ML","year":"2014","unstructured":"Westergaard ML, Hansen EH, Gl\u00fcmer C, et al.. Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review. Cephalalgia. 2014, 34:409-25. 10.1177\/0333102413512033","journal-title":"Cephalalgia"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/0333102412438977","article-title":"The prevalence of primary headache disorders in Russia: a countrywide survey","volume":"32","author":"Ayzenberg I","year":"2012","unstructured":"Ayzenberg I, Katsarava Z, Sborowski A, et al.. The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia. 2012, 32:373-81. 10.1177\/0333102412438977","journal-title":"Cephalalgia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2009.01913.x","article-title":"Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study","volume":"30","author":"Scher AI","year":"2010","unstructured":"Scher AI, Lipton RB, Stewart WF, Bigal M. Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study. Cephalalgia. 2010, 30:321-8. 10.1111\/j.1468-2982.2009.01913.x","journal-title":"Cephalalgia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-011-0391-8","article-title":"Management of primary chronic headache in the general population: the Akershus study of chronic headache","volume":"13","author":"Kristoffersen ES","year":"2012","unstructured":"Kristoffersen ES, Grande RB, Aaseth K, et al.. Management of primary chronic headache in the general population: the Akershus study of chronic headache. J Headache Pain. 2012, 13:113-20. 10.1007\/s10194-011-0391-8","journal-title":"J Headache Pain"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-018-0875-x","article-title":"Medication-overuse headache: a widely recognized entity amidst ongoing debate","volume":"19","author":"Vandenbussche N","year":"2018","unstructured":"Vandenbussche N, Laterza D, Lisicki M, et al.. Medication-overuse headache: a widely recognized entity amidst ongoing debate. J Headache Pain. 2018, 19:50. 10.1186\/s10194-018-0875-x","journal-title":"J Headache Pain"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/0333102411410082","article-title":"Epidemiology of medication overuse headache in the general Swedish population","volume":"31","author":"Jonsson P","year":"2011","unstructured":"Jonsson P, Hedenrud T, Linde M. Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia. 2011, 31:1015-22. 10.1177\/0333102411410082","journal-title":"Cephalalgia"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2018-002048","article-title":"Medication-overuse headache","volume":"19","author":"Wakerley BR","year":"2019","unstructured":"Wakerley BR. Medication-overuse headache. Pract Neurol. 2019, 19:399-403. 10.1136\/practneurol-2018-002048","journal-title":"Pract Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232322","article-title":"Consumers' awareness, attitude and associated factors towards self-medication in Hail, Saudi Arabia","volume":"15","author":"Ansari M","year":"2020","unstructured":"Ansari M, Alanazi A, Moin A. Consumers' awareness, attitude and associated factors towards self-medication in Hail, Saudi Arabia. PLoS One. 2020, 15:e0232322. 10.1371\/journal.pone.0232322","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2020.37.51.24098","article-title":"Current self-medication practices in the Kingdom of Saudi Arabia: an observational study","volume":"37","author":"Al-Ghamdi S","year":"2020","unstructured":"Al-Ghamdi S, Alfauri TM, Alharbi MA, et al.. Current self-medication practices in the Kingdom of Saudi Arabia: an observational study. Pan Afr Med J. 2020, 37:51. 10.11604\/pamj.2020.37.51.24098","journal-title":"Pan Afr Med J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2011.03612.x","article-title":"The cost of headache disorders in Europe: the Eurolight project","volume":"19","author":"Linde M","year":"2012","unstructured":"Linde M, Gustavsson A, Stovner LJ, et al.. The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol. 2012, 19:703-11. 10.1111\/j.1468-1331.2011.03612.x","journal-title":"Eur J Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-15-31","article-title":"The impact of headache in Europe: principal results of the Eurolight project","volume":"15","author":"Steiner TJ","year":"2014","unstructured":"Steiner TJ, Stovner LJ, Katsarava Z, et al.. The impact of headache in Europe: principal results of the Eurolight project. J Headache Pain. 2014, 15:31. 10.1186\/1129-2377-15-31","journal-title":"J Headache Pain"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","year":"2017","unstructured":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016. a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017, 390:1211-59. 10.1016\/S0140-6736(17)32154-2","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-15-10","article-title":"Should we educate about the risks of medication overuse headache?","volume":"15","author":"Lai JT","year":"2014","unstructured":"Lai JT, Dereix JD, Ganepola RP, et al.. Should we educate about the risks of medication overuse headache?. J Headache Pain. 2014, 15:10. 10.1186\/1129-2377-15-10","journal-title":"J Headache Pain"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417736898","article-title":"National awareness campaign to prevent medication-overuse headache in Denmark","volume":"38","author":"Carlsen LN","year":"2018","unstructured":"Carlsen LN, Westergaard ML, Bisgaard M, et al.. National awareness campaign to prevent medication-overuse headache in Denmark. Cephalalgia. 2018, 38:1316-25. 10.1177\/0333102417736898","journal-title":"Cephalalgia"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.24911\/ijmdc.51-1607078616","article-title":"Exploration of Saudi\u2019s general population\u2019s awareness about paracetamol (acetaminophen) overuse headache: a cross- sectional inquiry in Riyadh, Saudi Arabia","volume":"5","author":"Alharbi B","year":"2021","unstructured":"Alharbi B, Anjum I, Altasan A, et al.. Exploration of Saudi\u2019s general population\u2019s awareness about paracetamol (acetaminophen) overuse headache: a cross- sectional inquiry in Riyadh, Saudi Arabia. Int J Med Dev Ctries. 2021, 5:249-54. 10.24911\/ijmdc.51-1607078616","journal-title":"Int J Med Dev Ctries"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-1081-1","article-title":"The prevalence of primary headache disorders in Saudi Arabia: a cross-sectional population-based study","volume":"21","author":"Al Jumah M","year":"2020","unstructured":"Al Jumah M, Al Khathaami AM, Kojan S, et al.. The prevalence of primary headache disorders in Saudi Arabia: a cross-sectional population-based study. J Headache Pain. 2020, 21:11. 10.1186\/s10194-020-1081-1","journal-title":"J Headache Pain"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-015-1280-z","article-title":"Smartphone usage in the 21st century: who is active on WhatsApp?","volume":"8","author":"Montag C","year":"2015","unstructured":"Montag C, B\u0142aszkiewicz K, Sariyska R, et al.. Smartphone usage in the 21st century: who is active on WhatsApp?. BMC Res Notes. 2015, 8:331. 10.1186\/s13104-015-1280-z","journal-title":"BMC Res Notes"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000252808.97649.21","article-title":"Migraine prevalence, disease burden, and the need for preventive therapy","volume":"68","author":"Lipton RB","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M, et al.. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007, 68:343-9. 10.1212\/01.wnl.0000252808.97649.21","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-022-01034-w","article-title":"Sex differences in chronic migraine: focusing on clinical features, pathophysiology, and treatments","volume":"26","author":"Tsai CK","year":"2022","unstructured":"Tsai CK, Tsai CL, Lin GY, et al.. Sex differences in chronic migraine: focusing on clinical features, pathophysiology, and treatments. Curr Pain Headache Rep. 2022, 26:347-55. 10.1007\/s11916-022-01034-w","journal-title":"Curr Pain Headache Rep"},{"key":"ref25","unstructured":"\u200eGeneral Authority for Statistics. Education and training survey. (2017). Accessed. July 1, 2022: https:\/\/www.stats.gov.sa\/en\/5656."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010860","article-title":"Consumer concerns about paracetamol: a retrospective analysis of a medicines call centre","volume":"6","author":"Lau SM","year":"2016","unstructured":"Lau SM, McGuire TM, van Driel ML. Consumer concerns about paracetamol: a retrospective analysis of a medicines call centre. BMJ Open. 2016, 6:e010860. 10.1136\/bmjopen-2015-010860","journal-title":"BMJ Open"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h3705","article-title":"Where are we now with paracetamol?","volume":"351","author":"Dear JW","year":"2015","unstructured":"Dear JW, Antoine DJ, Park BK. Where are we now with paracetamol?. BMJ. 2015, 351:h3705. 10.1136\/bmj.h3705","journal-title":"BMJ"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/0333102419876909","article-title":"Monitoring chronic headache and medication-overuse headache prevalence in Denmark","volume":"40","author":"Westergaard ML","year":"2020","unstructured":"Westergaard ML, Lau CJ, Alles\u00f8e K, et al.. Monitoring chronic headache and medication-overuse headache prevalence in Denmark. Cephalalgia. 2020, 40:6-18. 10.1177\/0333102419876909","journal-title":"Cephalalgia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/107001-the-prevalence-and-level-of-awareness-of-medication-overuse-headache-in-qassim-province-saudi-arabia-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:06Z","timestamp":1707507546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/107001-the-prevalence-and-level-of-awareness-of-medication-overuse-headache-in-qassim-province-saudi-arabia-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.28101","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,17]]}}}